Pfizer says clinical trials have shown that its COVID-19 vaccine is safe and effective for children aged 5 to 11 years-old. Richard Zussman reports.
- Pfizer sends initial kids’ COVID-19 vaccine trial data to Health Canada
- U.S. parents await results as kids’ COVID-19 vaccine nears approval
- COVID-19: Quebec hopes to begin vaccinating youngsters by year’s end, health minister says